CCMH
GILD icon

Cornerstone Capital Management Holdings’s Gilead Sciences GILD Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$56M Buy
782,405
+25,652
+3% +$1.95M 0.39% 43
2017
Q3 		$61.3M Sell
756,753
-62,966
-8% -$4.81M 0.48% 36
2017
Q2 		$58M Sell
819,719
-101,427
-11% -$6.75M 0.46% 35
2017
Q1 		$62.6M Buy
921,146
+31,173
+4% +$2.19M 0.48% 31
2016
Q4 		$63.7M Buy
889,973
+39,152
+5% +$2.91M 0.49% 29
2016
Q3 		$67.3M Buy
850,821
+137,243
+19% +$11.1M 0.5% 28
2016
Q2 		$59.5M Buy
713,578
+13,901
+2% +$1.23M 0.48% 33
2016
Q1 		$64.3M Sell
699,677
-22,748
-3% -$2.05M 0.54% 30
2015
Q4 		$73.1M Buy
722,425
+21,123
+3% +$2.2M 0.6% 26
2015
Q3 		$68.9M Buy
701,302
+25,805
+4% +$2.87M 0.64% 23
2015
Q2 		$79.1M Buy
675,497
+1,109
+0.2% +$121K 0.7% 17
2015
Q1 		$66.2M Buy
674,388
+1,323
+0.2% +$134K 0.62% 20
2014
Q4 		$63.4M Buy
673,065
+162,320
+32% +$16.8M 0.65% 21
2014
Q3 		$54.4M Buy
510,745
+88,153
+21% +$8.63M 0.59% 26
2014
Q2 		$35M Buy
422,592
+12,230
+3% +$952K 0.39% 45
2014
Q1 		$29.1M Sell
410,362
-19,707
-5% -$1.55M 0.34% 54
2013
Q4 		$32.3M Sell
430,069
-282,190
-40% -$19.6M 0.37% 46
2013
Q3 		$44.8M Sell
712,259
-46,778
-6% -$2.8M 0.54% 31
2013
Q2 		$38.9M Buy
+759,037
New +$39.6M 0.48% 33

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Cornerstone Capital Management Holdings's GILD Position: Q4 2017 in Review

Cornerstone Capital Management Holdings increased its Gilead Sciences (GILD) stake by 3.4% in Q4 2017, buying an estimated $1.95M and bringing the position to 782,405 shares worth $56M. The position accounts for 0.39% of the portfolio, ranked #43.

Cornerstone Capital Management Holdings first reported a position in GILD in Q2 2013 and has held it in 19 quarters since. The position peaked at $79.1M in Q2 2015. 1,574 funds tracked by Wall St. Rank hold GILD as of Q4 2017.

  • Cornerstone Capital Management Holdings held 782,405 shares of Gilead Sciences worth $56M as of Q4 2017.
  • Cornerstone Capital Management Holdings bought 25,652 Gilead Sciences shares in Q4 2017, an estimated $1.95M.
  • Gilead Sciences made up 0.39% of Cornerstone Capital Management Holdings's portfolio in Q4 2017, its #43 holding.
  • Cornerstone Capital Management Holdings first reported a position in Gilead Sciences in Q2 2013 and has held it in 19 quarters since.
  • Cornerstone Capital Management Holdings's Gilead Sciences position peaked at $79.1M in Q2 2015.
  • 1,574 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2017.

Based on Cornerstone Capital Management Holdings's 13F filing for Q4 2017, filed 14 Feb 2018.